In New York City before World War II, all oral leases ended on May 1. On the same day, a vast number of the city’s renters would pick up and change residences. This phenomenon was known, appropriately ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Millions of Americans will wake up on Wednesday to a host of new laws ...

July marks the start of major changes to federal student loans. Whether you are repaying your loans or taking out new ones, you may be affected by these new policies. Many of the biggest changes are ...

Several new Mississippi laws concerning the state budget, criminal justice, and education will take effect on July 1. Judges will receive significant pay raises, and changes were made to the state ...

GLP-1 receptor agonists (GLP-1 RAs) are associated with reduced incidence of breast cancer among women with overweight or obesity, according to two observational studies. One found that GLP-1 RA users ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Real-world ASCO data link GLP-1 drugs to markedly longer survival across common cancers, raising new questions on mechanism and trials. Patients with cancer who used glucagon-like peptide-1 receptor ...

Shaquille O’Neal—the retired NBA megastar, entrepreneur, commentator, student and much more—is on one. At 54-years-old, he is maybe the busiest he’s ever been: O’Neal is launching Dunkman this summer, ...

After the SpaceX IPO is launched, Elon Musk will be the CEO and largest shareholder in two publicly traded companies valued at over $1 trillion. Musk has said he sees SpaceX SPCX and Tesla TSLA ...

June 8 (Reuters) - Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is not a cause for alarm, a large new data analysis ...

The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects. By Dani Blum Reporting from the American Diabetes Association Scientific Sessions conference ...